|
|
The Study of the Blooming Effect in High-Field MRI at 7 T |
Zhu Yurong1, Gao Yunyu1, Han Jijun1, Wang Jiajia1, XinXuegang1,2#* |
1(School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China) 2(School of Medicine, South China University of Technology, Guangzhou 510006, China) |
|
|
Abstract Magnetic susceptibility can be regarded as an intrinsic property of matter. Different tissues tend to have different magnetic susceptibility due to the differences in composition and structure. Effectively uses of the magnetic susceptibility may provide additional information of the structure and function of the organization. Based on this new imaging contrast mechanism, Susceptibility-weighted imaging emerged. There were some studies that have found that specific tissues could be extended under certain conditions due to the difference in magnetic susceptibility, which was called the blooming effect. As the basis, a comprehensive and accurate assessment of the blooming effect was important for the further application of SWI in clinical. In this paper, the related research of blooming effect was carried out systematically. Combined the silico and the ex-vivo experiment, we built the relationship between the susceptibility, echo times and size with the blooming effect using the number of the pixels and the blooming factor as the evaluation indexes. The silico result showed that, the susceptibility and echo times were positively correlated with the blooming effect. In this experiment, the magnitude and phase blooming factor could be up to 37. But in the model with 0.5 voxel radius, the blooming factor obtained by SWI could be up to 51. In addition, the results of ex-vitro experiments showed that the blooming factor in the diameter of 0.3 mm and 0.46 mm models could be up to 13.25 and 10.75 respectively. So that the smaller the radius of the model, the more obvious the blooming effect could be. The results of this research has important reference value to promote the development of SWI and early detection of diseases.
|
Received: 27 September 2019
|
|
Corresponding Authors:
*E-mail: xxg@smu.edu.cn
|
About author:: #(Member, Chinese Society of Biomedical Engineering) |
|
|
|
[1] Haacke EM, Reichenbach JR. Susceptibility weighted imaging in MRI: Basic concepts and clinical applications[M]. Hoboken: John Wiley & Sons, 2014: 17-31. [2] Simon AB, Buxton RB. Understanding the dynamic relationship between cerebral blood flow and the BOLD signal: Implications for quantitative functional MRI [J]. Neuroimage, 2015, 116: 158-167. [3] Acosta-Cabronero J, Machts J, Schreiber S, et al. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis[J]. Radiology, 2018, 289(1): 195-203. [4] Liu C, Li W, Tong KA, et al. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain[J]. Journal of Magnetic Resonance Imaging, 2015, 42(1): 23-41. [5] Duyn JH. Studying brain microstructure with magnetic susceptibility contrast at high-field[J]. Neuroimage, 2018, 168: 152-161. [6] Ward RJ,Zucca FA, Duyn JH, et al. The role of iron in brain ageing and neurodegenerative disorders[J]. The Lancet Neurology, 2014, 13(10):1045-1060. [7] 娄亚先, 郑罡, 曹力, 等. 磁共振相位成像原理及其影像技术实现[J]. 生物物理学报, 2013, 29(6):407-413. [8] Haacke EM, Xu Y, Cheng YCN, et al. Susceptibility weighted imaging (SWI)[J]. Magnetic Resonance in Medicine, 2004, 52(3): 612-618. [9] Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker[J]. Magnetic Resonance in Medicine, 2015, 73(1): 82-101. [10] Schrag M, Mcauley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study [J]. Acta Neuropathologica, 2010, 119(3):291-302. [11] De Reuck J, Auger F, Cordonnier C, et al. Comparison of 7.0-T T2*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates[J]. Cerebrovascular Diseases, 2011, 31(5): 511-517. [12] Vernooij MW, Ikram MA, Wielopolski PA, et al. Cerebral microbleeds: Accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection[J]. Radiology, 2008, 248(1): 272-277. [13] Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: Histopathological correlation of neuroimaging[J]. Cerebrovascular Diseases, 2011, 32(6): 528-534. [14] Buch S, Cheng YCN, Hu J, et al. Determination of detection sensitivity for cerebral microbleeds using susceptibility-weighted imaging[J]. NMR in Biomedicine, 2017, 30(4): e3551. [15] Shams S, Martola J, Cavallin L, et al. SWI or T2*: Which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska imaging dementia study[J]. American Journal of Neuroradiology, 2015, 36(6): 1089-1095. [16] Brown RW, Cheng YCN, Haacke EM, et al. Magnetic resonance imaging: Physical principles and sequence design[M]. Hoboken: John Wiley & Sons, 2014: 325-345. [17] Neelavalli J, Cheng YCN, Jing JM, et al. Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation[J]. Journal of Magnetic Resonance Imaging, 2010, 29(4):937-948. [18] Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: Technical aspects and clinical applications, part 1[J]. American Journal of Neuroradiology, 2009, 30(1): 19-30. [19] Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: A guide to detection and interpretation[J]. The Lancet Neurology, 2009, 8(2): 165-174. [20] Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging[J]. Journal of Magnetic Resonance Imaging, 2009, 29(3): 537-544. [21] Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier-and later-onset Parkinson’s disease and normal subjects[J]. Magnetic Resonance Imaging, 1999, 17(2): 213-222. [22] Bilgic B, Pfefferbaum A, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping[J]. Neuroimage, 2012, 59(3): 2625-2635. |
|
|
|